Beneficial Effect of OPC-8212 (3,4-Dihydro-6-[4-(3,4-Dimethoxybenzoyl)-1-Piperazinyl]-2(1H)-Quinolinone) on Myocardial Oxygen Consumption in Dogs with Ischemic Heart Failure : PANEL DISCUSSION ON OPINIONS OF CARDIOTONIC DRUGS : 49th Annual Scientific Sess

概要

論文の詳細を見る
The effect of a new inotropic agent, OPC-8212 (2(1H)-quinolinone derivative), on myocardial oxygen consumption (MV^^・O_2) following intravenous administration (1 and 3 mg/kg/min) was studied in normal and ischemic failing hearts in open chest dogs. Ischemic failing heart was obtained by intracoronary injection of 15-μm microspheres and volume loading. OPC-8212 significantly increased LV mad dP/dt and decreased mean aortic pressure, whereas heart rate was not altered in both normal and failing hearts. Despite the remarkable positive inotropic effect, this agent did not increase MV^^・O_2 in the normal hearts and even decreased MV^^・O_2 in the ischemic failing hearts associated with a decrease in LV end-diastolic pressure and hence, LV chamber size. These results indicate that OPC-8212 does not increase myocardial oxygen demand, probably because the increase in MV^^・O_2 by positive inotropic effect is offset by a decrease in MV^^・O_2 due to a decrease in chamber size. Thus, OPC-8212 may be promising for the treatment of congestive heart failure with reduced coronary flow reserve.
社団法人日本循環器学会の論文
1986-07-20